The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Stage

Acquired Unit | Acquired

Valuation

$0000 

About SalvaRx Group - Immuno-Oncology Assets

The SalvaRx Group is a drug discovery and development company focused on immune-oncology; SalvaRx invests in novel cancer immuno-therapies and provides its portfolio companies with operational support ranging from direct operation of subsidiaries to advisory or part-time involvement in more established companies.

SalvaRx Group - Immuno-Oncology Assets Headquarter Location

Commerce House, 1 Bowring Road Ramsey

Isle of Man, England, IM8 2LQ,

United Kingdom

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.